Fidelity Disruptors Fund

Fidelity Disruptors Fund

FGDFX
Fidelity Disruptors FundUS flagNASDAQ
- -
USD
- -
- -
No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChat
Sector
Financial Services
Industry
Asset Management
Address
245 Summer Street Boston MA United States of America 02210
IPO Date
Apr 16, 2020
Business
Fidelity Disruptors Fund (FGDFX) is an actively managed open-end mutual fund that seeks long-term growth of capital by investing in a combination of five underlying Fidelity thematic funds focused on disruptive innovation themes: automation, communications, finance, medicine, and technology. The fund allocates assets equally across these component funds—Fidelity Disruptive Automation Fund (FBOTX), Fidelity Disruptive Communications Fund (FNETX), Fidelity Disruptive Finance Fund (FNTEX), Fidelity Disruptive Medicine Fund (FMEDX), and Fidelity Disruptive Technology Fund (FTEKX)—each of which normally invests at least 80% of assets in equity securities of companies engaged in innovative business models, emerging industries, or technologies poised to disrupt incumbents, including industrial robotics and artificial intelligence (automation); social media, 5G infrastructure, and Internet of Things (communications); digital payments, internet banks, and disruptive lending/insurance (finance); gene therapy, robotic surgery, genomics, and digital health platforms (medicine); and cloud computing, big data, and mobile platforms (technology). Launched on April 16, 2020, and managed by a team at Fidelity Management & Research Company LLC headquartered in Boston, Massachusetts, the fund targets growth-oriented investors with exposure to global equities across market capitalizations, sectors, and regions without benchmark constraints, employing quantitative portfolio construction to mitigate volatility while emphasizing long-term fundamental outlooks. In a significant strategic shift announced on November 22, 2022, Fidelity Investments planned the conversion of FGDFX and its five underlying mutual funds into actively managed exchange-traded funds (ETFs) with tickers FDIF, FBOT, FDCF, FMED, and FDTX, respectively, completed in June 2023 to offer shareholders lower net expenses (reduced to 0.50%), intraday trading flexibility, greater holdings transparency, and enhanced tax efficiency while maintaining identical investment objectives and substantially similar strategies. This conversion expanded Fidelity's active ETF lineup in the thematic disruptive category, aligning with growing investor demand for ETF wrappers on targeted growth strategies amid a shift from mutual funds. No further major structural changes, acquisitions, partnerships, funding rounds, or liquidations involving FGDFX have been reported through late 2025, with the fund continuing operations under its original mutual fund structure and demonstrating year-to-date returns of approximately 20.91% as of recent data.